237 related articles for article (PubMed ID: 19251200)
1. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial.
Gold MR; Adler S; Fauchier L; Haffajee C; Ip J; Kainz W; Kawasaki R; Prakash A; Táborský M; Waller T; Wilson V; Li S; Hoffmann E;
Heart Rhythm; 2009 Mar; 6(3):295-301. PubMed ID: 19251200
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI).
Gold MR; Hoffmann E;
Am Heart J; 2006 Aug; 152(2):231-6. PubMed ID: 16875902
[TBL] [Abstract][Full Text] [Related]
3. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
[TBL] [Abstract][Full Text] [Related]
4. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry.
Lewalter T; Yang A; Pfeiffer D; Ruiter J; Schnitzler G; Markert T; Asklund M; Przibille O; Welz A; Esmailzadeh B; Linhart M; Lüderitz B
Pacing Clin Electrophysiol; 2006 Feb; 29(2):124-34. PubMed ID: 16492296
[TBL] [Abstract][Full Text] [Related]
5. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
[TBL] [Abstract][Full Text] [Related]
6. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
[TBL] [Abstract][Full Text] [Related]
7. Septal atrial pacing for the prevention of atrial fibrillation.
Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
[TBL] [Abstract][Full Text] [Related]
9. The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.
Russo V; Nigro G; DI Meo F; Papa AA; Cioppa ND; Proietti R; Russo MG; Calabrò R; Politano L
Acta Myol; 2014 Dec; 33(3):127-35. PubMed ID: 25873781
[TBL] [Abstract][Full Text] [Related]
10. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
11. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
[TBL] [Abstract][Full Text] [Related]
12. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
[TBL] [Abstract][Full Text] [Related]
13. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.
Padeletti L; Pürerfellner H; Adler SW; Waller TJ; Harvey M; Horvitz L; Holbrook R; Kempen K; Mugglin A; Hettrick DA;
J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1189-95. PubMed ID: 14678133
[TBL] [Abstract][Full Text] [Related]
14. Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study.
Hemels ME; Ruiter JH; Molhoek GP; Veeger NJ; Wiesfeld AC; Ranchor AV; van Trigt M; Pilmeyer A; Van Gelder IC; ;
Europace; 2008 Mar; 10(3):306-13. PubMed ID: 18245199
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
16. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
[TBL] [Abstract][Full Text] [Related]
17. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ;
Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388
[TBL] [Abstract][Full Text] [Related]
18. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation.
Gillis AM; Koehler J; Morck M; Mehra R; Hettrick DA
Heart Rhythm; 2005 Aug; 2(8):791-6. PubMed ID: 16051111
[TBL] [Abstract][Full Text] [Related]
19. Is dual site better than single site atrial pacing in the prevention of atrial fibrillation?
Leclercq JF; De Sisti A; Fiorello P; Halimi F; Manot S; Attuel P
Pacing Clin Electrophysiol; 2000 Dec; 23(12):2101-7. PubMed ID: 11202254
[TBL] [Abstract][Full Text] [Related]
20. Effects of continuous and triggered atrial overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients.
Schuchert A; Rebeski HP; Peiffer T; Bub E; Dietz A; Mortensen K; Aydin MA; Camm J; Gazarek S; Meinertz T;
Pacing Clin Electrophysiol; 2008 Aug; 31(8):929-34. PubMed ID: 18684247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
